1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics

Healthcare Analysis & Statistics

1-30 of about 400 reports

Fabry disease - Pipeline Insight, 2021

  • $ 2000
  • December 2021
  • 70 pages

“Fabry Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Fabry Disease pipeline landscape. It covers the pipeline drug profiles, ...

  • United States
  • World
  • Neurological Disorder
  • Industry analysis

Herpes simplex - Pipeline Insight, 2021

  • $ 2000
  • December 2021
  • 60 pages

“Herpes Simplex – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Herpes Simplex pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • United States
  • Therapy
  • Infectious Disease
  • Industry analysis

Basal cell carcinoma - Pipeline Insight, 2021

  • $ 2000
  • October 2021
  • 70 pages

“Basal cell carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Basal cell carcinoma pipeline landscape. It covers the pipeline ...

  • World
  • Cancer
  • Industry analysis

Spinal Cord Injury - Pipeline Insight, 2021

  • $ 2000
  • September 2021
  • 80 pages

“Spinal Cord Injury - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Spinal Cord Injury pipeline landscape. It covers the pipeline drug ...

  • World
  • Taiwan
  • Neurological Disorder
  • Industry analysis

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2021

  • $ 2000
  • September 2021
  • 80 pages

“Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Acetylcholine Receptor (AChR) Antagonists ...

  • World
  • Therapy
  • Depression
  • Industry analysis

Persistent Epithelial Defect - Epidemiology forecast- 2030

  • $ 3750
  • August 2021
  • 80 pages

‘Persistent Epithelial Defect (PED)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Persistent Epithelial Defect (PED), historical and forecasted epidemiology in the ...

  • Spain
  • Germany
  • Epidemiology
  • Industry analysis

Anemia - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 150 pages

‘Iron deficiency anemia (IDA)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the IDA across the several selected cancer types, historical and forecasted IDA epidemiology ...

  • Spain
  • France
  • Epidemiology
  • Industry analysis

Major Depressive Disorder - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 175 pages

‘Major Depressive Disorder (MDD)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Major Depressive Disorder (MDD), historical and forecasted epidemiology in the United ...

  • Spain
  • France
  • Depression
  • Industry analysis

Human Papillomavirus 16-positive (HPV16+) Cancers - Epidemiology forecast- 2030

  • $ 3750
  • August 2021
  • 80 pages

‘HPV 16+ Cancer –Epidemiology Forecast—2030’ report delivers an in-depth understanding of HPV 16+ cancer, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, ...

  • France
  • Germany
  • Epidemiology
  • Industry analysis
  • Cancer Incidence

X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology forecast- 2030

  • $ 3750
  • August 2021
  • 68 pages

DelveInsight’s ’X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted X-Linked Retinitis Pigmentosa ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Functional Dyspepsia - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 64 pages

‘Functional Dyspepsia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of Functional Dyspepsia, historical and forecasted epidemiology in the United States, EU5 (Germany, ...

  • Spain
  • Germany
  • Digestive System Disorder
  • Industry analysis

ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 80 pages

‘ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology ...

  • United States
  • Spain
  • Breast Cancer
  • Industry analysis

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology forecast- 2030

  • $ 4750
  • August 2021
  • 180 pages

‘Chronic Obstructive Pulmonary Disease (COPD)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted ...

  • United States
  • Spain
  • Respiratory Disease
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence

Endometriosis - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Endometriosis – Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Endometriosis pipeline landscape. It covers the pipeline drug profiles, ...

  • Japan
  • World
  • Genitourinary System Disease
  • Industry analysis

Celiac Disease - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Celiac Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Celiac Disease pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Digestive System Disorder
  • Industry analysis

Epidermolysis bullosa - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Epidermolysis bullosa - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Epidermolysis bullosa pipeline landscape. It covers the pipeline ...

  • World
  • Dermatological Condition
  • Industry analysis

Osteosarcoma - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 100 pages

“Osteosarcoma - Pipeline Insight, 2021,” report provides comprehensive insights about 38+ companies and 38+ pipeline drugs in Osteosarcoma pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Cancer
  • Industry analysis

Soft Tissue Sarcoma - Pipeline Insight, 2021

  • $ 3000
  • July 2021
  • 248 pages

“Soft Tissue Sarcoma - Pipeline Insight, 2021,” report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers the pipeline ...

  • World
  • Europe
  • Cancer
  • Industry analysis

Pulmonary Arterial Hypertension - Pipeline Insight, 2021

  • $ 2500
  • July 2021
  • 100 pages

“Pulmonary Arterial Hypertension - Pipeline Insight, 2021,” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Pulmonary Arterial Hypertension pipeline landscape. ...

  • World
  • Australia
  • Hypertension
  • Therapy
  • Industry analysis

Immune thrombocytopenia - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 80 pages

“Immune thrombocytopenia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Immune thrombocytopenia pipeline landscape. It covers the pipeline ...

  • World
  • Blood Disease
  • Industry analysis

Frontotemporal dementia - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 60 pages

“Frontotemporal dementia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Frontotemporal dementia pipeline landscape. It covers the pipeline ...

  • World
  • Europe
  • Neurological Disorder
  • Industry analysis

Heart failure - Pipeline Insight, 2021

  • $ 3000
  • July 2021
  • 60 pages

“Heart failure - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Heart failure pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Heart Failure
  • Industry analysis

Hepatitis C - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 100 pages

“Hepatitis C - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hepatitis C pipeline landscape. It covers the pipeline drug profiles, including ...

  • World
  • Hepatitis
  • Industry analysis

Glioblastoma - Pipeline Insight, 2021

  • $ 3000
  • July 2021
  • 120 pages

“Glioblastoma - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Therapy
  • Brain Cancer
  • Industry analysis

HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021

  • $ 2500
  • July 2021
  • 90 pages

“HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in HR+/ HER2-VE Breast Cancer pipeline landscape. It covers ...

  • World
  • China
  • Breast Cancer
  • Industry analysis

Hemophilia A - Pipeline Insight, 2021

  • $ 2500
  • July 2021
  • 90 pages

“Hemophilia A - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Blood Disease
  • Industry analysis

Hidradenitis Suppurativa - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 70 pages

“Hidradenitis Suppurativa - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the ...

  • World
  • Europe
  • Autoimmune Disease
  • Industry analysis
  • Drug Approval

Nonmuscle invasive bladder cancer - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 80 pages

“Nonmuscle invasive bladder cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Nonmuscle invasive bladder cancer pipeline landscape. ...

  • World
  • Bladder Cancer
  • Industry analysis

Chronic Spontaneous Urticaria - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 70 pages

“Chronic Spontaneous Urticaria - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Spontaneous Urticaria pipeline landscape. It covers ...

  • World
  • United States
  • Dermatological Condition
  • Industry analysis

Cutaneous T-cell Lymphoma - Pipeline Insight, 2021

  • $ 2000
  • July 2021
  • 100 pages

“Cutaneous T-cell Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Cutaneous T-cell Lymphoma pipeline landscape. It covers the ...

  • World
  • Lymphoma
  • Industry analysis
About 47000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Maternal Health Demographic Impact in the US

  • January 2022
  • 43 pages
  • United States
  • Maternal Health
  • Industry analysis
  • Maternal Mortality Rate

US Economic Analysis January 2022

US Country Report January 2022


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on